Redcare Pharmacy NV (RDC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Redcare Pharmacy NV (RDC) has a cash flow conversion efficiency ratio of -0.039x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-18.82 Million ≈ $-22.00 Million USD) by net assets (€479.20 Million ≈ $560.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Redcare Pharmacy NV to measure how many days the company can operate on defensive assets alone.
Redcare Pharmacy NV - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Redcare Pharmacy NV's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Redcare Pharmacy NV Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Redcare Pharmacy NV ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China High-Speed Railway Technology
SHE:000008
|
0.015x |
|
Whitestone REIT
NYSE:WSR
|
0.008x |
|
Genus Power Infrastructures Limited
NSE:GENUSPOWER
|
-0.083x |
|
First Hi-tec Enterprise Co Ltd
TWO:5439
|
0.065x |
|
Shaanxi Fenghuo Electronics Co Ltd
SHE:000561
|
-0.062x |
|
ArcherMind Technology Nanjing Co Ltd
SHE:300598
|
0.008x |
|
Beijing Strong Biotechnologies Inc
SHE:300406
|
0.046x |
|
Shandong Jinjing Science and Technology Stock Co Ltd
SHG:600586
|
-0.032x |
Annual Cash Flow Conversion Efficiency for Redcare Pharmacy NV (2019–2025)
The table below shows the annual cash flow conversion efficiency of Redcare Pharmacy NV from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Redcare Pharmacy NV (RDC) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €479.20 Million ≈ $560.24 Million |
€31.00 Million ≈ $36.24 Million |
0.065x | +49.28% |
| 2024-12-31 | €509.97 Million ≈ $596.21 Million |
€22.10 Million ≈ $25.84 Million |
0.043x | -61.07% |
| 2023-12-31 | €552.03 Million ≈ $645.38 Million |
€61.46 Million ≈ $71.85 Million |
0.111x | +235.61% |
| 2022-12-31 | €354.63 Million ≈ $414.60 Million |
€-29.11 Million ≈ $-34.03 Million |
-0.082x | -393.10% |
| 2021-12-31 | €415.41 Million ≈ $485.66 Million |
€11.63 Million ≈ $13.60 Million |
0.028x | -33.11% |
| 2020-12-31 | €425.14 Million ≈ $497.03 Million |
€17.80 Million ≈ $20.81 Million |
0.042x | +131.72% |
| 2019-12-31 | €232.76 Million ≈ $272.12 Million |
€-30.73 Million ≈ $-35.92 Million |
-0.132x | -- |
About Redcare Pharmacy NV
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare P… Read more